EP3616686
SUBLINGUAL FORMULATION OF RILUZOLE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.11.2015EP published:
19.5.2021EP application number:
19186196.2
EPO information:
European Patent Register
Max expiry date:
16.11.2035
Title:
SUBLINGUAL FORMULATION OF RILUZOLE
Timeline
Today
17.11.2015EP application
19.5.2021EP Publication
Owner
Name:
Biohaven Pharmaceutical Holding Company Ltd.Address:
234 Church Street Suite 301, New Haven, CT 06520, US
Inventor
Name:
CORIC, VladimirAddress:
Madison, CT 06443, US
Name:
BERMAN, Robert, M.Address:
New Haven, CT 06511, US
Priority
Number:
201462083094 PDate:
21.11.2014Country:
US
Classification
Categories:
A61K 9/00, A61K 31/428, A61K 9/20, A61K 9/08, A61K 47/20, A61K 47/26, A61P 25/00, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30